Successful treatment of chronic eosinophilic pneumonia with anti-IgE therapy.
J Korean Med Sci
; 27(10): 1261-4, 2012 Oct.
Article
em En
| MEDLINE
| ID: mdl-23091327
ABSTRACT
Anti-IgE therapy, using recombinant humanized anti-IgE antibodies, is clinically effective in patients with eosinophil-related disorders such as allergic asthma, allergic rhinitis, and chronic urticaria. Chronic eosinophilic pneumonia tends to respond promptly to systemic corticosteroid therapy, however; relapses are common following corticosteroid tapering. We treated two patients (17- and 19-yr-old males) of chronic eosinophilic pneumonia whose symptoms were cough and dyspnea on exertion. The symptoms were recurrent while tapering off corticosteroid. They were treated with anti-IgE antibody without recurrence for 2 yr and 15 months. Here, we first describe clinical experience of the 2 cases of chronic eosinophilic pneumonia.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Eosinofilia Pulmonar
/
Anticorpos Anti-Idiotípicos
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
Limite:
Adolescent
/
Adult
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article